• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.10% Nasdaq Up0.49%

    Sorrento Therapeutics, Inc. (SRNE)

    -NasdaqCM
    6.47 Up 0.11(1.73%) 2:48PM EDT - Nasdaq Real Time Price
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015
    Total Revenue 988   1,337   1,103   1,173  
    Cost of Revenue359  523  604  314  
    Gross Profit 629   814   499   859  
    Operating Expenses
    Research Development7,777  8,288  7,244  7,971  
    Selling General and Administrative4,495  10,130  4,711  3,072  
    Non Recurring13,000  (55)24,068   -  
    Others111  111  111  349  
    Total Operating Expenses25,383  18,474  36,134   -  
    Operating Income or Loss (24,754) (17,660) (35,635) (10,533)
    Income from Continuing Operations
    Total Other Income/Expenses Net5,533  (3,337)69,275   -  
    Earnings Before Interest And Taxes(19,720)(25,038)33,640  (10,533)
    Interest Expense307  375  396  442  
    Income Before Tax(20,027)(25,413)33,244  (10,975)
    Income Tax Expense -  1,186  35,323  (17)
    Minority Interest1,637  3,123  1,140   -  
    Net Income From Continuing Ops(18,889)(27,517)(939)(10,958)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (18,390) (23,476) (939) (10,958)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (18,390) (23,476) (939) (10,958)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.